Keiichi Tsukinoki

Expression and Localization of Chromogranin A Gene and Protein in Human Submandibular Gland

Human saliva chromogranin A (CgA) is clinically promising as a psychological stress marker. However, expression of CgA is poorly understood in humans, although salivary gland localization of CgA in other mammals, such as rodents and horses, has been demonstrated. In the present study, we investigated the expression and localization of CgA in the human submandibular gland (HSG) using various methods. CgA was consistently localized in serous and ductal cells in HSG, as detected by immunohistochemistry and in situhybridization. Reactivity was stronger in serous cells than in ductal cells. In addition, strong immunoreactivity for CgA was observed in the saliva matrix of ductal cavities. Western blotting gave one significant immunoreactive band of 68 kDa in the adrenal gland, HSG and saliva. Finally, CgA was detected in secretory granules of serous and ductal cells by immunoelectron microscopy. In conclusion, CgA in humans is produced by HSG and secreted into saliva.

Telomerase activity in oral cancer

Telomerase activity can be detected in most human cancers. This is consistent with the telomere hypothesis, which predicts upregulation of telomerase expression after a number of mitotic divisions to prevent the progressive and catastrophic loss of telomeres. However, telomerase has not been fully analyzed in oral cancers. In this report, telomerase activity was analyzed in 31 human oral malignant tumors, 11 leukoplakias, three pleomorphic adenomas, and 40 samples taken from normal tissues of the oral cavity, using a polymerase chain reaction (PCR)-based telomeric repeat amplification protocol assay. Telomerase activity was detected in most oral cancers [squamous cell carcinoma (SCC), non-Hodgkins lymphoma, adenoid cystic carcinomas, mucoepidermoid carcinoma, osteosarcoma, acinic cell carcinoma, rhabdomyosarcoma]. None of the normal tissues or pleomorphic adenomas displayed telomerase activity. In leukoplakia, telomerase activity was seen in moderate or severe dysplastic tissue and carcinoma in situ. Mild dysplasia did not reveal telomerase activity. In SCC, there was no clear association between relative telomerase activity and grade or stage. These results suggest that detection of telomerase activity in oral tissues could be used to differentiate malignant from benign or normal tissues.

Allowing animals to bite reverses the effects of immobilization stress on hippocampal neurotrophin expression

Acute immobilization stress alters the expression of neurotrophins, including brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), in rat hippocampus. We found that biting may be associated with reduction of systemic stress responses. The purpose of this study was to examine whether neurotrophin expression in rat hippocampus is influenced by biting. Rats were exposed to immobilization stress for 2 h (stress group without biting) or biting for the latter half of 2-hour immobilization stress (biting group). Adrenocorticotropic hormone (ACTH) and corticosterone levels were markedly elevated in the stress group, while the increases in ACHT and corticosterone were suppressed in the biting group. Decreased BDNF mRNA and increased NT-3 mRNA expression in hippocampus were detected on real-time polymerase chain reaction (PCR) in the stress group. The decrease in BDNF mRNA under acute immobilization stress was recovered by biting. In addition, the magnitude of increase in NT-3 mRNA was decreased. No changes in expression of tyrosine receptor kinase B or C, the receptors for BDNF and NT-3, respectively, were observed in this model. These findings suggest that biting influences the alterations in neurotrophin levels induced by acute immobilization stress in rat hippocampus.

Submandibular Glands Contribute to Increases in Plasma BDNF Levels

Brain-derived neurotrophic factor (BDNF) promotes survival and differentiation of neural cells in the central and peripheral nervous systems. BDNF has been detected in plasma, but its source has not yet been established. Expression of BDNF mRNA has been identified in the submandibular glands when male rats are exposed to acute immobilization stress. In the present study, we investigated whether plasma BDNF is influenced by the submandibular glands in this model. Acute immobilization stress for 60 min significantly increased the level of plasma BDNF. However, plasma BDNF elevation was markedly suppressed in bilaterally sialoadenectomized rats. There were no significant differences between stressed (60 min) and non-stressed rats with respect to the BDNF mRNA expression in the hippocampus, heart, lung, liver, pancreas, or spleen, as determined by real-time polymerase chain-reaction. These findings suggest that the submandibular glands may be the primary source of plasma BDNF in conditions of acute immobilization stress.

Schwannoma of the mental nerve: usefulness of preoperative imaging: a case report

Schwannoma of the head and neck region is relatively uncommon. We report a case of schwannoma arising from the left mental nerve. A 21-year-old male presented at our hospital with a painless swelling of the left cheek. Because the lesion had rapidly increased in size, a malignant tumor was suspected. Magnetic resonance imaging (MRI), computed tomography, and ultrasonography were performed. MRI and ultrasonography revealed that the tumor was connected to the mental nerve. Both MRI and ultrasonography were found to be useful in making a preoperative diagnosis. It was possible to determine prior to surgery that this was a peripheral nerve sheath tumor. The lesion was completely resected. The pathological diagnosis was Antoni type A schwannoma. There has been no sign of recurrence 1 year after surgery.

Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma.

Clinical efficacy of gefitinib (ZD1839, Iressa), which is an inhibitor specific for epidermal growth factor (EGF) receptor tyrosine kinase, has been shown in non‐small‐cell lung carcinoma patients with EGF receptor mutations, so these mutations are useful marker(s) to find a responder for the drug. Recent studies have shown that the EGF receptor gene mutation is rare in squamous cell carcinoma in the esophageal and head and neck regions. We previously reported that the expression of the chemokine BRAK/CXCL14 in head and neck squamous cell carcinoma (HNSCC) cells was down‐regulated by EGF treatment, and that forced expression of BRAK in tumor cells decreased the tumorigenicity of the cells in xenografts. Thus, we investigated the relationship between restoration of BRAK expression by gefitinib and the efficacy of the drug for tumor suppression. We found that EGF down‐regulated BRAK expression through the MEK–extracellular signal regulated kinase pathway and that this down‐regulated expression was restored by gefitinib in vitro. Oral administration of gefitinib significantly (P < 0.001) reduced tumor growth of xenografts of three HNSCC cell lines (HSC‐2, HSC‐3, and HSC‐4), in female athymic nude mice, accompanied by an increase in BRAK expression specifically in tumor tissue. This tumor‐suppressing effect of the drug was not observed in the case of BRAK non‐expressing cells. Furthermore introduction of BRAK shRNA vector reduced both the expression levels of BRAK in HSC‐3 cells and the antitumor efficacy of gefitinib in vivo. Our data showing an inverse relationship between BRAK expression levels in tumor cells and the tumor growth rate indicate that the gefitinib‐induced increase in BRAK expression is beneficial for tumor suppression in vivo. (Cancer Sci 2009)

Immobilization stress induces BDNF in rat submandibular glands.

Brain-derived neurotrophic factor (BDNF) promotes survival and differentiation of the cells of the central and peripheral nervous systems. BDNF has been identified in non-neural tissue, including the heart, lung, platelets, lymphocytes, and lacrimal glands. Immobilization stress modifies BDNF mRNA expression in some organs. The present study examines the effect of immobilization stress on BDNF, and its receptor TrkB, in male rat submandibular glands. Increased BDNF mRNA and protein expression were observed in duct cells as a result of immobilization stress, as demonstrated by real-time PCR, Western blot, immunohistochemistry, and analysis by microdissection. TrkB mRNA was not detected in salivary gland tissue, or oral or esophageal mucosa, by RT-PCR. Rat submandibular gland was thus identified as an organ which expresses BDNF. Furthermore, the results of this study suggest that increased salivary BDNF expression occurs following immobilization stress.

Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles

Mass spectrometry (MS)-based metabolomic methods enable simultaneous profiling of hundreds of salivary metabolites, and may be useful to diagnose a wide range of diseases using saliva. However, few studies have evaluated the effects of physiological or environmental factors on salivary metabolomic profiles. Therefore, we used capillary electrophoresis-MS to analyze saliva metabolite profiles in 155 subjects with reasonable oral hygiene, and examined the effects of physiological and environmental factors on the metabolite profiles. Overall, 257 metabolites were identified and quantified. The global profiles and individual metabolites were evaluated by principle component analysis and univariate tests, respectively. Collection method, collection time, sex, body mass index, and smoking affected the global metabolite profiles. However, age also might contribute to the bias in sex and collection time. The profiles were relatively unaffected by other parameters, such as alcohol consumption and smoking, tooth brushing, or the use of medications or nutritional supplements. Temporomandibular joint disorders had relatively greater effects on salivary metabolites than other dental abnormalities (e.g., stomatitis, tooth alignment, and dental caries). These findings provide further insight into the diversity and stability of salivary metabolomic profiles, as well as the generalizability of disease-specific biomarkers.

Essential Role of the Adhesion Receptor LFA-1 for T Cell-Dependent Fulminant Hepatitis

Viral hepatitis affects more than 2 billion people worldwide. In particular, no effective treatment exists to abrogate death and liver damage in fulminant hepatitis. Activation of T cells is an initial and critical event in the pathogenesis of liver damage in autoimmune and viral hepatitis. The precise molecular mechanisms that induce T cell-mediated hepatocyte injury remain largely unclear. In mice, T cell-dependent hepatitis and acute liver damage can be modeled using ConA. In this study, we examined the role of the adhesion receptor LFA-1 in ConA-induced acute hepatic damage using LFA-1−/− (CD11a) mice. Massive liver cell apoptosis and metabolic liver damage were observed in LFA-1+/+ mice following ConA injection. By contrast, LFA-1−/− mice were completely resistant to ConA-induced hepatitis and none of the LFA-1−/− mice showed any hepatic damage. Whereas activated hepatic T cells remained in the liver in LFA-1+/+ mice, activated T cells were rapidly cleared from the livers of LFA-1−/− mice. Mechanistically, T cells from LFA-1−/− mice showed markedly reduced cytotoxicity toward liver cells as a result of impaired, activation-dependent adhesion. Importantly, adoptive transfer of hepatic T cells from LFA-1+/+ mice, but not from LFA-1−/− mice, sensitized LFA-1−/− mice to ConA-induced hepatitis. Thus, LFA-1 expression on T cells is necessary and sufficient for T cell-mediated liver damage in vivo. These results provide the first genetic evidence on an adhesion receptor, LFA-1, that has a crucial role in fulminant hepatitis. These genetic data identify LFA-1 as a potential key target for the treatment of T cell-mediated hepatitis and the prevention of liver damage.

Effects of Weekly One-Hour Hatha Yoga Therapy on Resilience and Stress Levels in Patients with Schizophrenia-Spectrum Disorders: An Eight-Week Randomized Controlled Trial

OBJECTIVE To examine the effects of Hatha yoga therapy on resilience, brain-derived neurotrophic factor (BDNF) levels, and salivary alpha amylase (SAA) activity in patients with schizophrenia-spectrum disorders. DESIGN AND PARTICIPANTS Single-blinded, randomized controlled study in which outpatients with schizophrenia or related psychotic disorders (according to International Classification of Diseases, 10th Revision) were randomly assigned to a yoga or a control group. SETTING November 2012-April 2013 at Yamanashi Prefectural Kita Hospital, Japan. INTERVENTIONS In the yoga group, patients received weekly 1-hour Hatha yoga sessions, in addition to regular treatment, for 8 weeks. Those in the control group underwent regular treatment, which included a daycare rehabilitation program. OUTCOME MEASURES Assessments included the 25-item Resilience Scale (RS), Positive and Negative Syndrome Scale (PANSS), plasma and salivary BDNF level, and SAA activity. RESULTS Fifty patients participated (25 in each group; mean age±standard deviation, 50.9±11.3 years; mean duration of illness, 25.0±10.3 years; mean total PANSS score, 78.2±17.3). No significant differences in changes in any variable from baseline to week 8 were found between the two groups (changes in the yoga group versus the control group: RS score, -1.6±19.9 versus 0.3±17.2; PANSS score, 0.5±12.0 versus 5.0±15.6; plasma BDNF, 41.6±377.0 pg/dl versus 73.4±346.0 pg/dl; SAA, -26.2±72.6 kU/l versus -13.8±68.0 kU/l, respectively). CONCLUSIONS Adjunct yoga therapy showed no positive changes in resilience level or stress markers. Duration and intensity of yoga sessions and the focus on patients with chronic illness may explain the negative observations in light of past positive evidence regarding yoga therapy.